Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
For patients with suspected DVT, CVR offers same-day rule-out evaluation
You can read the FDAs patient safety guidance on unapproved GLP-1 drugs used for weight loss
Shippers should pay the cost of destruction and present proof of destruction to the FDA
Sources Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial (2024) Journal of the American Medical Association [Accessed 2 December 2025] Dosing Schedule | Ozempic (semaglutide) (2025) [Accessed 2 December 2025] GIP and GLP1, the two incretin hormones: Similarities and differences (2010) Journal of Diabetes Investigation [Accessed 2 December 2025] Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021) New England Journal of Medicine [Accessed 2 December 2025]
US$ 25.98
US$ 27.96
US$ 24.72
US$ 28.76
US$ 20.29
US$ 26.46
